An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study.

[1]  J. Vries,et al.  Sarcoidosis: assessment of disease severity using HRCT , 2003, European Radiology.

[2]  R. Baughman,et al.  Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. , 2010, Chest.

[3]  M. Iannuzzi,et al.  Epidemiology, demographics, and genetics of sarcoidosis. , 1998, Seminars in respiratory infections.

[4]  C. Ng,et al.  A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. , 1999, Journal of thoracic imaging.

[5]  H. Shigemitsu,et al.  Pulmonary hypertension and granulomatous vasculitis in sarcoidosis , 2007, Current opinion in pulmonary medicine.

[6]  H. Hutchings,et al.  Sarcoidosis: a long-term follow up study. , 2000, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[7]  A. Perry,et al.  Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. , 1995, Archives of pathology & laboratory medicine.

[8]  Anand Devaraj,et al.  Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. , 2010, Radiology.

[9]  L. Ladelli,et al.  Right heart impairment in sarcoidosis: haemodynamic and echocardiographic study. , 1983, European journal of respiratory diseases.

[10]  J. Remy,et al.  Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. , 1994, Radiology.

[11]  G. Rizzato.  Recent advances in sarcoidosis. , 1986, European journal of respiratory diseases.

[12]  J. Tooze,et al.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.

[13]  J. Reich.  Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy. , 2002, Chest.

[14]  T. Kozuka,et al.  Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. , 2005, Chest.

[15]  J. Zieliński,et al.  Pulmonary haemodynamics at rest and during exercise in patients with sarcoidosis. , 1984, Respiration; international review of thoracic diseases.

[16]  Elkan F. Halpern,et al.  Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Massachusetts General Hospital Lung Transplantation Program. , 1997, Academic radiology.

[17]  M. Humbert,et al.  Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis , 2005, Thorax.

[18]  J. Bavaria,et al.  Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. , 2001, Chest.

[19]  M. Prokop,et al.  Intraocular sarcoidosis: association of clinical characteristics of uveitis with positive chest high-resolution computed tomography findings , 2009, British Journal of Ophthalmology.

[20]  R. Baughman,et al.  Predicting respiratory failure in sarcoidosis patients. , 1997, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[21]  S. Nathan,et al.  Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics , 2005, European Respiratory Journal.

[22]  M. Iannuzzi,et al.  Diagnosis of sarcoidosis: when is a peek good enough? , 2000, Chest.

[23]  Daniel A Culver,et al.  A concise review of pulmonary sarcoidosis. , 2011, American journal of respiratory and critical care medicine.

[24]  D. Hansell,et al.  Interstitial lung disease in systemic sclerosis: a simple staging system. , 2008, American journal of respiratory and critical care medicine.

[25]  H. Collard,et al.  Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. , 2012, American journal of respiratory and critical care medicine.

[26]  J. Vestbo,et al.  Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. , 1994, Sarcoidosis.

[27]  S. Nathan,et al.  Pulmonary Hypertension in Sarcoidosis. , 2015, Clinics in chest medicine.

[28]  M. Mishima,et al.  Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. , 2006, Chest.

[29]  M. Schwarz,et al.  A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. , 1986, The American review of respiratory disease.

[30]  D. Hansell,et al.  The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. , 2008, Radiology.

[31]  A. Nicholson,et al.  Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. , 2003, American journal of respiratory and critical care medicine.

[32]  G Gamsu,et al.  CT-determined pulmonary artery diameters in predicting pulmonary hypertension. , 1984, Investigative radiology.

[33]  A. Teirstein,et al.  Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. , 2005, Chest.

[34]  A. Silman,et al.  Statistical methods for assessing observer variability in clinical measures. , 1992, BMJ.

[35]  T. McLoud,et al.  Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Massachusetts General Hospital Lung Transplantation Program. , 1997, Academic radiology.

[36]  S. Nathan,et al.  Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. , 2007, Chest.

[37]  G. Gibson.  Standardised lung function testing. , 1993, The European respiratory journal.

[38]  J. Zielinski,et al.  Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis. , 1990, The European respiratory journal.

[39]  陶仲为.  Sarcoidosis , 2009 .